Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...
This study is committed to searching for inhibitors of deacetylase SIRT2 within the natural product database via computer-aided drug design techniques. A comprehensive computer-aided drug design ...
Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...
“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...
they want more data and may not trust SGLT2 inhibitors yet. Other HCPs want cardiologists to be leaders in this space, feeling that they should use these drugs in practice and share their ...
SGLT2 inhibitors help lower blood sugar by causing the kidneys to eliminate more sugar in the urine. Farxiga is used alongside diet and exercise and, in some cases, other medications to help control ...
Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...
Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of ... initiation Given that PPIs are one of the most commonly prescribed drug classes worldwide, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback